Corvus Pharmaceuticals Inc (CRVS)

Cash & Equivalents

$18.91M

Quarterly · Period ending: · USD

CRVS logo

CRVS Cash & Equivalents

Latest reported$18.91M
CRVS Quarterly Cash & Equivalents ($12.52M → $18.91M)
High-resolution chart · PNG

CRVS cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Corvus Pharmaceuticals Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
18,905,000
40,102,000
4,576,000
2,867,000
14,691,000
4,999,000
8,740,000
4,680,000
14,841,000
7,456,000
12,620,000
20,105,000
7,658,000
9,654,000
13,159,000
24,588,000
28,477,000
31,460,000
63,458,000
72,295,000
58,915,000
45,104,000
16,455,000
22,976,000
20,705,000
23,498,000
5,154,000
9,067,000
30,183,000
38,976,000
114,597,000
40,747,000
28,068,000
102,565,000
90,055,000
44,104,000
34,095,000
10,487,000
134,896,000
5,576,000
4,343,000
4,065,000
4,105,000
79,599,000
-12,517,000
12,517,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.